All of the following eligibility requirements must be met: Medical evaluation and provider approval as a suitable treatment candidate 26 consecutive weekly doses of the prescribed injectable form of compounded semaglutide or compounded tirzepatide - no skipped doses Adherence to dietary guidance, exercise recommendations, and all scheduled follow-up appointments Weekly check-ins through the Eden member portal Weekly posts in Eden's private Facebook community Submission of two verification videos: one within the first 15 days of treatment and one at the end of the six-month period - each must show the patient's face, a scale reading, and the date and time The guarantee does not apply to tablet or liquid forms of compounded semaglutide or tirzepatide - injectable forms only
(2024) Obesity Prevention Source
In research settings: Micro-dosing is common due to BPC-157s potent activity
Melanotan 1 (MT-1) Research Grade Peptide 10mg | Buy in Australia Melanotan 1 (MT-1) 10mg is a premium research-grade peptide supplied as a lyophilised powder for laboratory and scientific research
2014 Jun 6;269:143-51 Authors: Karalija A, Novikova LN, Kingham PJ, Wiberg M, Novikov LN Abstract Traumatic spinal cord injury induces a long-standing inflammatory response in the spinal cord tissue, leading to a progressive apoptotic death of spinal cord neurons and glial cells